Weizhen Wu
Impact in
- Genetics top 5%
- Mesenchymal stem cell research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Surgery 17
- Pancreatic function and diabetes 6
-
- RNA Research and Splicing 3
- Co-authors
- Ming Jen Tan (22 shared papers)Shunliang Yang (18 shared papers)Lianghu Huang (7 shared papers)Jin Chen (7 shared papers)Lianming Liao (7 shared papers)Hu Zhao (6 shared papers)Jinquan Cai (5 shared papers)Tengyue Zeng (5 shared papers)
- Journals
- Journal of Biochemical and Molecular Toxicology (2 papers)Cytotherapy (2 papers)Blood Coagulation & Fibrinolysis (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Weizhen Wu
48 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Genetics 249
- Cancer Research 260
- Transplantation 42
- Urology 74
- Obstetrics and Gynecology 78
Countries citing papers authored by Weizhen Wu
This map shows the geographic impact of Weizhen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhen Wu more than expected).
Fields of papers citing papers by Weizhen Wu
This network shows the impact of papers produced by Weizhen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhen Wu. The network helps show where Weizhen Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weizhen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 144 | |
| 2 | 2015 | 134 | |
| 3 | 2014 | 91 | |
| 4 | 2017 | 75 | |
| 5 | 2014 | 69 | |
| 6 | 2018 | 68 | |
| 7 | 2015 | 64 | |
| 8 | 2008 | 53 | |
| 9 | 2013 | 51 | |
| 10 | 2010 | 49 | |
| 11 | 2016 | 48 | |
| 12 | 2013 | 43 | |
| 13 | 2013 | 41 | |
| 14 | 2018 | 32 | |
| 15 | 2022 | 31 | |
| 16 | 2019 | 30 | |
| 17 | 2013 | 28 | |
| 18 | 2008 | 27 | |
| 19 | Alemtuzumab induction therapy in highly sensitized kidney transplant recipients. | 2011 | 24 |
| 20 | 2017 | 24 |
About Weizhen Wu
Weizhen Wu is a scholar working on Surgery, Molecular Biology, Genetics, Cancer Research and Hematology, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (8 papers), Pancreatic function and diabetes (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Renal Transplantation Outcomes and Treatments (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), RNA Research and Splicing (3 papers), Renal Diseases and Glomerulopathies (3 papers) and Gestational Diabetes Research and Management (3 papers). The work is most often cited by research in Genetics (249 citations), Cancer Research (260 citations), Transplantation (42 citations), Urology (74 citations) and Obstetrics and Gynecology (78 citations). Weizhen Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Ming Jen Tan, Shunliang Yang, Lianghu Huang, Jin Chen, Lianming Liao, Hu Zhao, Jinquan Cai, Tengyue Zeng, Zhixian Wu and Dong Wang. Their work appears in journals such as Journal of Biochemical and Molecular Toxicology, Cytotherapy, Blood Coagulation & Fibrinolysis, Journal of Pharmacology and Experimental Therapeutics and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.